Literature DB >> 25030969

Cardiac MR perfusion imaging: where we are.

Riccardo Marano1, Luigi Natale, Amedeo Chiribiri, Federica Pirro, Valentina Silvestri, Giuseppe Coppola, Lorenzo Bonomo.   

Abstract

To date, several clinical and multicentre studies have demonstrated the accuracy of perfusion cardiac magnetic resonance to detect ischaemia in comparison with quantitative coronary angiography, other noninvasive diagnostic techniques (single photon emission computed tomography; positron-emission tomography), and invasive haemodynamic measurements (fractional flow reserve). Moreover, the favourable safety profile and increasing availability contribute to make perfusion cardiac magnetic resonance one of the modalities of choice for the detection of myocardial ischaemia. Recently, the first evidence of the prognostic value of perfusion cardiac magnetic resonance results has also become available. This review summarises the technical and interpretation key points of perfusion cardiac magnetic resonance scan, the clinical indications, the most recent available literature about its diagnostic performance and prognostic value, and how perfusion cardiac magnetic resonance compares with other noninvasive techniques.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25030969     DOI: 10.1007/s11547-014-0435-7

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  69 in total

1.  k-t BLAST and k-t SENSE: dynamic MRI with high frame rate exploiting spatiotemporal correlations.

Authors:  Jeffrey Tsao; Peter Boesiger; Klaas P Pruessmann
Journal:  Magn Reson Med       Date:  2003-11       Impact factor: 4.668

2.  Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve.

Authors:  Marco A Costa; Steven Shoemaker; Hideki Futamatsu; Chris Klassen; Dominick J Angiolillo; Minh Nguyen; Alan Siuciak; Paul Gilmore; Martin M Zenni; Luis Guzman; Theodore A Bass; Norbert Wilke
Journal:  J Am Coll Cardiol       Date:  2007-07-23       Impact factor: 24.094

3.  Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease.

Authors:  Ricardo C Cury; Cesar A M Cattani; Luiz A G Gabure; Douglas J Racy; Jose M de Gois; Uwe Siebert; Sergio S Lima; Thomas J Brady
Journal:  Radiology       Date:  2006-07       Impact factor: 11.105

4.  Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve.

Authors:  Johannes Rieber; Armin Huber; Isabelle Erhard; Silvia Mueller; Michael Schweyer; Andreas Koenig; Thomas M Schiele; Karl Theisen; Uwe Siebert; Stefan O Schoenberg; Maximilian Reiser; Volker Klauss
Journal:  Eur Heart J       Date:  2006-05-23       Impact factor: 29.983

5.  MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial.

Authors:  Juerg Schwitter; Christian M Wacker; Norbert Wilke; Nidal Al-Saadi; Ekkehart Sauer; Kalman Huettle; Stefan O Schönberg; Andreas Luchner; Oliver Strohm; Hakan Ahlstrom; Thorsten Dill; Nadja Hoebel; Tamas Simor
Journal:  Eur Heart J       Date:  2012-03-04       Impact factor: 29.983

Review 6.  Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease.

Authors:  Michèle Hamon; Georges Fau; Guillaume Née; Javed Ehtisham; Rémy Morello; Martial Hamon
Journal:  J Cardiovasc Magn Reson       Date:  2010-05-19       Impact factor: 5.364

7.  Myocardial first-pass perfusion magnetic resonance imaging: a multicenter dose-ranging study.

Authors:  S D Wolff; J Schwitter; R Coulden; M G Friedrich; D A Bluemke; R W Biederman; E T Martin; A J Lansky; F Kashanian; T K F Foo; P E Licato; C R Comeau
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690

8.  Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial.

Authors:  Brian R Leaker; B O'Connor; Trevor T Hansel; Peter J Barnes; Lixen Meng; Vandana S Mathur; Hsiao D Lieu
Journal:  J Nucl Cardiol       Date:  2008-04-14       Impact factor: 5.952

Review 9.  Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis.

Authors:  Kiran R Nandalur; Ben A Dwamena; Asim F Choudhri; Mohan R Nandalur; Ruth C Carlos
Journal:  J Am Coll Cardiol       Date:  2007-09-17       Impact factor: 24.094

10.  Quantification of absolute myocardial perfusion in patients with coronary artery disease: comparison between cardiovascular magnetic resonance and positron emission tomography.

Authors:  Geraint Morton; Amedeo Chiribiri; Masaki Ishida; Shazia T Hussain; Andreas Schuster; Andreas Indermuehle; Divaka Perera; Juhani Knuuti; Stacey Baker; Erik Hedström; Paul Schleyer; Michael O'Doherty; Sally Barrington; Eike Nagel
Journal:  J Am Coll Cardiol       Date:  2012-09-19       Impact factor: 24.094

View more
  2 in total

Review 1.  Practical instructions for using drugs in CT and MR cardiac imaging.

Authors:  Giuseppe Rovere; Agostino Meduri; Giancarlo Savino; Francesco Ciriaco Flammia; Francesca Lo Piccolo; Maria Rachele Pia Carafa; Anna Rita Larici; Luigi Natale; Biagio Merlino; Riccardo Marano
Journal:  Radiol Med       Date:  2020-08-24       Impact factor: 3.469

2.  MDCT assessment of CAD in type-2 diabetic subjects with diabetic neuropathy: the role of Charcot neuro-arthropathy.

Authors:  Riccardo Marano; Dario Pitocco; Enrico Di Stasio; Giancarlo Savino; Biagio Merlino; Carlo Trani; Federica Pirro; Claudia Rutigliano; Carolina Santangelo; Aurelian Costin Minoiu; Luigi Natale; Lorenzo Bonomo
Journal:  Eur Radiol       Date:  2015-07-03       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.